Obicetrapib

CAS No. 866399-87-3

Obicetrapib( AMG-899 | AMG899 | TA-8995 | DEX-001 )

Catalog No. M16296 CAS No. 866399-87-3

Obicetrapib (AMG-899, TA-8995, DEX-001) is a potent, ora cholesteryl ester transfer protein (CETP) inhibitor for treatment of dyslipidaemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 212 In Stock
5MG 154 In Stock
10MG 216 In Stock
25MG 390 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Obicetrapib
  • Note
    Research use only, not for human use.
  • Brief Description
    Obicetrapib (AMG-899, TA-8995, DEX-001) is a potent, ora cholesteryl ester transfer protein (CETP) inhibitor for treatment of dyslipidaemia.
  • Description
    Obicetrapib (AMG-899, TA-8995, DEX-001) is a potent, ora cholesteryl ester transfer protein (CETP) inhibitor for treatment of dyslipidaemia.Dyslipidemia Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AMG-899 | AMG899 | TA-8995 | DEX-001
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    CETP
  • Recptor
    CETP
  • Research Area
    Cardiovascular Disease
  • Indication
    Dyslipidemia

Chemical Information

  • CAS Number
    866399-87-3
  • Formula Weight
    722.609
  • Molecular Formula
    C32H31F9N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=NC=C(C=N4)OCCCC(=O)O
  • Chemical Name
    4-[2-[[3,5-bis(trifluoromethyl)phenyl]methyl-[(2R,4S)-1-ethoxycarbonyl-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinolin-4-yl]amino]pyrimidin-5-yl]oxybutanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ford J, et al. Br J Clin Pharmacol. 2014 Sep;78(3):498-508. 2. Hovingh GK, et al. Lancet. 2015 Aug 1;386(9992):452-60.
molnova catalog
related products
  • Evacetrapib

    Evacetrapib (LY2484595) is a potent and selective inhibitor of cholesteryl ester transfer protein (CETP) with IC50 of 5.5 nM for human recombinant CETP protein.

  • BMS-212122

    BMS-212122 (UNII-0Z473OO6GB) is a potent inhibitor of microsomal triglyceride transfer protein (MTP) and has shown hypolipidemic effects in animal studies.BMS-212122 significantly reduced lipid content and monocyte-derived (CD68+) cells in atherosclerotic plaques.

  • BMS-795311

    BMS-795311 is a potent and orally available CETP inhibitor with IC50 of 3.8 nM, inhibits cholesteryl ester (CE) transfer with IC50 of 0.22 uM.